• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global HIV Vaccines Market Size, Status and Forecast 2020-2026

report cover
  • 30 July 2020
  • Healthcare
  • 91 Pages
  • Report Code: 24LS-15868
  • Formate :   
Download FREE Report Sample Download PDF File

HIV Vaccines -MARKET ADVISORY SERVICES

HIV Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Argos Therapeutics
Bionor Pharma
Janssen Global Services
Genecure
Geovax,
Paxvax Corporation
Inovio Pharmaceuticals
Glaxosmithkline
Sanofi

Market segment by Type, the product can be split into
Phase I
Phase II
Phase III
Market segment by Application, split into
Research Institute
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Vaccines Revenue
1.4 Market by Type
1.4.1 Global HIV Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Phase I
1.4.3 Phase II
1.4.4 Phase III
1.5 Market by Application
1.5.1 Global HIV Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Research Institute
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global HIV Vaccines Market Perspective (2015-2026)
2.2 Global HIV Vaccines Growth Trends by Regions
2.2.1 HIV Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 HIV Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Vaccines Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top HIV Vaccines Players by Market Size
3.1.1 Global Top HIV Vaccines Players by Revenue (2015-2020)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Vaccines Market Concentration Ratio
3.2.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2019
3.3 HIV Vaccines Key Players Head office and Area Served
3.4 Key Players HIV Vaccines Product Solution and Service
3.5 Date of Enter into HIV Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global HIV Vaccines Historic Market Size by Type (2015-2020)
4.2 Global HIV Vaccines Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global HIV Vaccines Market Size by Application (2015-2020)
5.2 Global HIV Vaccines Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America HIV Vaccines Market Size (2015-2020)
6.2 HIV Vaccines Key Players in North America (2019-2020)
6.3 North America HIV Vaccines Market Size by Type (2015-2020)
6.4 North America HIV Vaccines Market Size by Application (2015-2020)

7 Europe
7.1 Europe HIV Vaccines Market Size (2015-2020)
7.2 HIV Vaccines Key Players in Europe (2019-2020)
7.3 Europe HIV Vaccines Market Size by Type (2015-2020)
7.4 Europe HIV Vaccines Market Size by Application (2015-2020)

8 China
8.1 China HIV Vaccines Market Size (2015-2020)
8.2 HIV Vaccines Key Players in China (2019-2020)
8.3 China HIV Vaccines Market Size by Type (2015-2020)
8.4 China HIV Vaccines Market Size by Application (2015-2020)

9 Japan
9.1 Japan HIV Vaccines Market Size (2015-2020)
9.2 HIV Vaccines Key Players in Japan (2019-2020)
9.3 Japan HIV Vaccines Market Size by Type (2015-2020)
9.4 Japan HIV Vaccines Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia HIV Vaccines Market Size (2015-2020)
10.2 HIV Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Vaccines Market Size by Application (2015-2020)

11 India
11.1 India HIV Vaccines Market Size (2015-2020)
11.2 HIV Vaccines Key Players in India (2019-2020)
11.3 India HIV Vaccines Market Size by Type (2015-2020)
11.4 India HIV Vaccines Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America HIV Vaccines Market Size (2015-2020)
12.2 HIV Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Vaccines Market Size by Type (2015-2020)
12.4 Central & South America HIV Vaccines Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Argos Therapeutics
13.1.1 Argos Therapeutics Company Details
13.1.2 Argos Therapeutics Business Overview
13.1.3 Argos Therapeutics HIV Vaccines Introduction
13.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020))
13.1.5 Argos Therapeutics Recent Development
13.2 Bionor Pharma
13.2.1 Bionor Pharma Company Details
13.2.2 Bionor Pharma Business Overview
13.2.3 Bionor Pharma HIV Vaccines Introduction
13.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2015-2020)
13.2.5 Bionor Pharma Recent Development
13.3 Janssen Global Services
13.3.1 Janssen Global Services Company Details
13.3.2 Janssen Global Services Business Overview
13.3.3 Janssen Global Services HIV Vaccines Introduction
13.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2015-2020)
13.3.5 Janssen Global Services Recent Development
13.4 Genecure
13.4.1 Genecure Company Details
13.4.2 Genecure Business Overview
13.4.3 Genecure HIV Vaccines Introduction
13.4.4 Genecure Revenue in HIV Vaccines Business (2015-2020)
13.4.5 Genecure Recent Development
13.5 Geovax,
13.5.1 Geovax, Company Details
13.5.2 Geovax, Business Overview
13.5.3 Geovax, HIV Vaccines Introduction
13.5.4 Geovax, Revenue in HIV Vaccines Business (2015-2020)
13.5.5 Geovax, Recent Development
13.6 Paxvax Corporation
13.6.1 Paxvax Corporation Company Details
13.6.2 Paxvax Corporation Business Overview
13.6.3 Paxvax Corporation HIV Vaccines Introduction
13.6.4 Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020)
13.6.5 Paxvax Corporation Recent Development
13.7 Inovio Pharmaceuticals
13.7.1 Inovio Pharmaceuticals Company Details
13.7.2 Inovio Pharmaceuticals Business Overview
13.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
13.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020)
13.7.5 Inovio Pharmaceuticals Recent Development
13.8 Glaxosmithkline
13.8.1 Glaxosmithkline Company Details
13.8.2 Glaxosmithkline Business Overview
13.8.3 Glaxosmithkline HIV Vaccines Introduction
13.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020)
13.8.5 Glaxosmithkline Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview
13.9.3 Sanofi HIV Vaccines Introduction
13.9.4 Sanofi Revenue in HIV Vaccines Business (2015-2020)
13.9.5 Sanofi Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. HIV Vaccines Key Market Segments

Table 2. Key Players Covered: Ranking by HIV Vaccines Revenue

Table 3. Ranking of Global Top HIV Vaccines Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Phase I

Table 6. Key Players of Phase II

Table 7. Key Players of Phase III

Table 8. Global HIV Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 9. Global HIV Vaccines Market Size by Regions (US$ Million): 2020 VS 2026

Table 10. Global HIV Vaccines Market Size by Regions (2015-2020) (US$ Million)

Table 11. Global HIV Vaccines Market Share by Regions (2015-2020)

Table 12. Global HIV Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 13. Global HIV Vaccines Market Share by Regions (2021-2026)

Table 14. Market Top Trends

Table 15. Key Drivers: Impact Analysis

Table 16. Key Challenges

Table 17. HIV Vaccines Market Growth Strategy

Table 18. Main Points Interviewed from Key HIV Vaccines Players

Table 19. Global HIV Vaccines Revenue by Players (2015-2020) (Million US$)

Table 20. Global HIV Vaccines Market Share by Players (2015-2020)

Table 21. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2019)

Table 22. Global HIV Vaccines by Players Market Concentration Ratio (CR5 and HHI)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players HIV Vaccines Product Solution and Service

Table 25. Date of Enter into HIV Vaccines Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 28. Global HIV Vaccines Market Size Share by Type (2015-2020)

Table 29. Global HIV Vaccines Revenue Market Share by Type (2021-2026)

Table 30. Global HIV Vaccines Market Size Share by Application (2015-2020)

Table 31. Global HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 32. Global HIV Vaccines Market Size Share by Application (2021-2026)

Table 33. North America Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 34. North America Key Players HIV Vaccines Market Share (2019-2020)

Table 35. North America HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 36. North America HIV Vaccines Market Share by Type (2015-2020)

Table 37. North America HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 38. North America HIV Vaccines Market Share by Application (2015-2020)

Table 39. Europe Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 40. Europe Key Players HIV Vaccines Market Share (2019-2020)

Table 41. Europe HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 42. Europe HIV Vaccines Market Share by Type (2015-2020)

Table 43. Europe HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 44. Europe HIV Vaccines Market Share by Application (2015-2020)

Table 45. China Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 46. China Key Players HIV Vaccines Market Share (2019-2020)

Table 47. China HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 48. China HIV Vaccines Market Share by Type (2015-2020)

Table 49. China HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 50. China HIV Vaccines Market Share by Application (2015-2020)

Table 51. Japan Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 52. Japan Key Players HIV Vaccines Market Share (2019-2020)

Table 53. Japan HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 54. Japan HIV Vaccines Market Share by Type (2015-2020)

Table 55. Japan HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 56. Japan HIV Vaccines Market Share by Application (2015-2020)

Table 57. Southeast Asia Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 58. Southeast Asia Key Players HIV Vaccines Market Share (2019-2020)

Table 59. Southeast Asia HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 60. Southeast Asia HIV Vaccines Market Share by Type (2015-2020)

Table 61. Southeast Asia HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 62. Southeast Asia HIV Vaccines Market Share by Application (2015-2020)

Table 63. India Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 64. India Key Players HIV Vaccines Market Share (2019-2020)

Table 65. India HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 66. India HIV Vaccines Market Share by Type (2015-2020)

Table 67. India HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 68. India HIV Vaccines Market Share by Application (2015-2020)

Table 69. Central & South America Key Players HIV Vaccines Revenue (2019-2020) (Million US$)

Table 70. Central & South America Key Players HIV Vaccines Market Share (2019-2020)

Table 71. Central & South America HIV Vaccines Market Size by Type (2015-2020) (Million US$)

Table 72. Central & South America HIV Vaccines Market Share by Type (2015-2020)

Table 73. Central & South America HIV Vaccines Market Size by Application (2015-2020) (Million US$)

Table 74. Central & South America HIV Vaccines Market Share by Application (2015-2020)

Table 75. Argos Therapeutics Company Details

Table 76. Argos Therapeutics Business Overview

Table 77. Argos Therapeutics Product

Table 78. Argos Therapeutics Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 79. Argos Therapeutics Recent Development

Table 80. Bionor Pharma Company Details

Table 81. Bionor Pharma Business Overview

Table 82. Bionor Pharma Product

Table 83. Bionor Pharma Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 84. Bionor Pharma Recent Development

Table 85. Janssen Global Services Company Details

Table 86. Janssen Global Services Business Overview

Table 87. Janssen Global Services Product

Table 88. Janssen Global Services Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 89. Janssen Global Services Recent Development

Table 90. Genecure Company Details

Table 91. Genecure Business Overview

Table 92. Genecure Product

Table 93. Genecure Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 94. Genecure Recent Development

Table 95. Geovax, Company Details

Table 96. Geovax, Business Overview

Table 97. Geovax, Product

Table 98. Geovax, Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 99. Geovax, Recent Development

Table 100. Paxvax Corporation Company Details

Table 101. Paxvax Corporation Business Overview

Table 102. Paxvax Corporation Product

Table 103. Paxvax Corporation Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 104. Paxvax Corporation Recent Development

Table 105. Inovio Pharmaceuticals Company Details

Table 106. Inovio Pharmaceuticals Business Overview

Table 107. Inovio Pharmaceuticals Product

Table 108. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 109. Inovio Pharmaceuticals Recent Development

Table 110. Glaxosmithkline Business Overview

Table 111. Glaxosmithkline Product

Table 112. Glaxosmithkline Company Details

Table 113. Glaxosmithkline Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 114. Glaxosmithkline Recent Development

Table 115. Sanofi Company Details

Table 116. Sanofi Business Overview

Table 117. Sanofi Product

Table 118. Sanofi Revenue in HIV Vaccines Business (2015-2020) (Million US$)

Table 119. Sanofi Recent Development

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HIV Vaccines Market Share by Type: 2020 VS 2026

Figure 2. Phase I Features

Figure 3. Phase II Features

Figure 4. Phase III Features

Figure 5. Global HIV Vaccines Market Share by Application: 2020 VS 2026

Figure 6. Research Institute Case Studies

Figure 7. Other Case Studies

Figure 8. HIV Vaccines Report Years Considered

Figure 9. Global HIV Vaccines Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global HIV Vaccines Market Share by Regions: 2020 VS 2026

Figure 11. Global HIV Vaccines Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global HIV Vaccines Market Share by Players in 2019

Figure 14. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Vaccines as of 2019

Figure 15. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2019

Figure 16. North America HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central & South America HIV Vaccines Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Bottom-up and Top-down Approaches for This Report

Figure 24. Data Triangulation

Figure 25. Key Executives Interviewed

Argos Therapeutics

Bionor Pharma

Janssen Global Services

Genecure

Geovax,

Paxvax Corporation

Inovio Pharmaceuticals

Glaxosmithkline

Sanofi

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3276

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase